Latest stories on NGEN
NG Energy International reports Q2 results
Seeking Alpha50 · neutralearnings
NervGen Pharma GAAP EPS of -C$0.37
Seeking Alpha34 · bearishearnings
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
Business Insider55 · neutralgeneral
NuGen Adds to Core Patent Portfolio for Future Needle-Free Platforms
StockTitan59 · neutralproduct/pr
NervGen Pharma: I Think The Biggest Risks Are Now Behind It
Seeking Alpha63 · neutralproduct/pr
NervGen rises as TD Cowen issues new Buy on lead asset
Seeking Alpha61 · neutralanalyst
NervGen Pharma Raises US$60 Million in Underwritten Offering to Fund NVG-291 Program
TipRanks24 · bearishgeneral
Biggest stock movers Friday: WDAY, ZM, and more
Seeking Alpha55 · neutralgeneral
NervGen Pharma prices 24M share public offering; warrants exercisable at $3.68
Seeking Alpha24 · bearishgeneral
NervGen Announces Pricing of US$60.0 Million Public Offering of Securities | NGEN Stock News
StockTitan28 · bearishgeneral
NervGen Announces Proposed Public Offering of Securities | NGEN Stock News
StockTitan24 · bearishgeneral
NervGen Pharma Advances NVG-291 Toward Registrational Trial as Q1 2026 Loss Narrows
TipRanks56 · neutralproduct/pr
NervGen Pharma GAAP EPS of -$0.02
Seeking Alpha34 · bearishearnings